On November 1, 2019, the Centers for Medicare and Medicaid Services (CMS) released the final 2020 rule for the Hospital Outpatient Prospective Payment System (HOPPS), which updates payment policy for services furnished to Medicare beneficiaries in hospital outpatient departments (HOPD).1 Although the policy update is often comprised of incremental refinements, this year’s HOPPS update contains a notable change with potentially widespread effects on cancer care delivery in the US: the final rule lowers the minimum level of supervision for hospital outpatient therapeutic services from “direct supervision” to “general supervision.” Herein we review the impetus behind this change and consider its effect on cancer care in regard to access, safety, and scope of practice.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Royce TJ, Basch E, Bekelman JE. Supervision Requirements in the 2020 Hospital Outpatient Prospective Payment System: Implications for Cancer Care in the United States. JAMA Oncol. 2020;6(6):819–820. doi:10.1001/jamaoncol.2020.0092
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: